Chandra Belani

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Morgensztern Daniel; Belani Chandra P
Novel cytotoxic agents.
Zamboni W C; Strychor S; Maruca L; Ramalingam S; Zamboni B A; Wu H; Friedland D M; Edwards R P; Stoller R G; Belani C P; Ramanathan R K
Pharmacokinetic study of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies.
Ciuleanu Tudor; Brodowicz Thomas; Zielinski Christoph; Kim Joo Hang; Krzakowski Maciej; Laack Eckart; Wu Yi-Long; Bover Isabel; Begbie Stephen; Tzekova Valentina; Cucevic Branka; Pereira Jose Rodrigues; Yang Sung Hyun; Madhavan Jayaprakash; Sugarman Katherine P; Peterson Patrick; John William J; Krejcy Kurt; Belani Chandra P
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Chandra Belani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Morgensztern Daniel; Belani Chandra P
Novel cytotoxic agents.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(11 Suppl 3):S1082-3.
2009: Zamboni W C; Strychor S; Maruca L; Ramalingam S; Zamboni B A; Wu H; Friedland D M; Edwards R P; Stoller R G; Belani C P; Ramanathan R K
Pharmacokinetic study of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies.
Clinical pharmacology and therapeutics 2009;86(5):519-26.
2009: Ciuleanu Tudor; Brodowicz Thomas; Zielinski Christoph; Kim Joo Hang; Krzakowski Maciej; Laack Eckart; Wu Yi-Long; Bover Isabel; Begbie Stephen; Tzekova Valentina; Cucevic Branka; Pereira Jose Rodrigues; Yang Sung Hyun; Madhavan Jayaprakash; Sugarman Katherine P; Peterson Patrick; John William J; Krejcy Kurt; Belani Chandra P
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study.
Lancet 2009;374(9699):1432-40.
2009: Ramanathan Ramesh K; Belani Chandra P; Singh Deepti A; Tanaka Michael; Lenz Heinz-Josef; Yen Yun; Kindler Hedy L; Iqbal Syma; Longmate Jeff; Mack Philip C; Lurje Georg; Gandour-Edwards Regina; Dancey Janet; Gandara David R
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.
Cancer chemotherapy and pharmacology 2009;64(4):777-83.
2009: Zamboni William C; Ramalingam Suresh; Friedland David M; Edwards Robert P; Stoller Ronald G; Strychor Sandra; Maruca Lauren; Zamboni Beth A; Belani Chandra P; Ramanathan Ramesh K
Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(4):1466-72.
2009: Ramalingam Suresh S; Belani Chandra P; Ruel Christopher; Frankel Paul; Gitlitz Barbara; Koczywas Marianna; Espinoza-Delgado Igor; Gandara David
Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(1):97-101.
2008: Belani Chandra P; Schreeder Marshall T; Steis Ronald G; Guidice Richard A; Marsland Thomas A; Butler Elizabeth H; Ramalingam Suresh S
Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study.
Cancer 2008;113(9):2512-7.
2008: Gandara David R; Lara Primo N; Natale Ronald; Belani Chandra
Progress in small-cell lung cancer: the lowest common denominator.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(26):4236-8.
2008: Ramalingam Suresh S; Belani Chandra P
Recent advances in the treatment of malignant pleural mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(9):1056-64.
2008: Yen Y; Lim Dean W; Chung Vincent; Morgan Robert J; Leong Lucille A; Shibata Stephen I; Wagman Lawrence D; Marx Howard; Chu Peiguo G; Longmate Jeffrey A; Lenz Heinz-Josef; Ramanathan Ramesh K; Belani Chandra P; Gandara David R
Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial.
American journal of clinical oncology 2008;31(4):317-22.
2008: Ramalingam Suresh; Perry Michael C; La Rocca Renato V; Rinaldi David; Gable Preston S; Tester William J; Belani Chandra P
Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer.
Cancer 2008;113(3):542-6.
2008: Ramalingam Suresh S; Egorin Merrill J; Ramanathan Ramesh K; Remick Scot C; Sikorski Rachel P; Lagattuta Theodore F; Chatta Gurkamal S; Friedland David M; Stoller Ronald G; Potter Douglas M; Ivy S Percy; Belani Chandra P
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3456-61.
2008: Pennathur Arjun; Luketich James D; Landreneau Rodney J; Ward Julie; Christie Neil A; Gibson Michael K; Schuchert Matthew; Cooper Kristi; Land Stephanie R; Belani Chandra P
Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
The Annals of thoracic surgery 2008;85(6):1930-6; discussion 1936-7.
2008: Ramalingam Suresh; Forster Judy; Naret Cynthia; Evans Terry; Sulecki Matt; Lu Haolan; Teegarden Paola; Weber Martin R; Belani Chandra P
Dual inhibition of the epidermal growth factor receptor with cetuximab, an IgG1 monoclonal antibody, and gefitinib, a tyrosine kinase inhibitor, in patients with refractory non-small cell lung cancer (NSCLC): a phase I study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(3):258-64.
2008: Socinski Mark A; Novello Silvia; Brahmer Julie R; Rosell Rafael; Sanchez Jose M; Belani Chandra P; Govindan Ramaswamy; Atkins James N; Gillenwater Heidi H; Pallares Cinta; Tye Lesley; Selaru Paulina; Chao Richard C; Scagliotti Giorgio V
Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):650-6.
2008: Ramanathan Ramesh K; Egorin Merrill J; Takimoto Chris H M; Remick Scot C; Doroshow James H; LoRusso Patricia A; Mulkerin Daniel L; Grem Jean L; Hamilton Anne; Murgo Anthony J; Potter Douglas M; Belani Chandra P; Hayes Michael J; Peng Bin; Ivy S Percy;
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):563-9.
2008: Belani Chandra P; Ramalingam Suresh; Perry Michael C; LaRocca Renato V; Rinaldi David; Gable Preston S; Tester William J
Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):468-73.
2008: Ramalingam Suresh S; Dahlberg Suzanne E; Langer Corey J; Gray Robert; Belani Chandra P; Brahmer Julie R; Sandler Alan B; Schiller Joan H; Johnson David H;
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(1):60-5.
2008: Ramalingam Suresh; Belani Chandra
Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions.
The oncologist 2008;13 Suppl 1():5-13.
2007: Owonikoko Taofeek K; Ragin Camille C; Belani Chandra P; Oton Ana B; Gooding William E; Taioli Emanuela; Ramalingam Suresh S
Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(35):5570-7.
2007: Feng Rentian; Oton Ana; Mapara Markus Y; Anderson Gülsüm; Belani Chandra; Lentzsch Suzanne
The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage.
British journal of haematology 2007;139(3):385-97.
2007: Herbst Roy S; O'Neill Vincent J; Fehrenbacher Louis; Belani Chandra P; Bonomi Philip D; Hart Lowell; Melnyk Ostap; Ramies David; Lin Ming; Sandler Alan
Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4743-50.
2007: Heymach John V; Johnson Bruce E; Prager Diane; Csada Edit; Roubec Jaromír; Pesek Milos; Spásová Irena; Belani Chandra P; Bodrogi István; Gadgeel Shirish; Kennedy Sarah J; Hou Jeannie; Herbst Roy S
Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4270-7.
2007: Charu Veena; Belani Chandra P; Gill Ahmad N; Bhatt Mukesh; Tomita Dianne; Rossi Greg; Ben-Jacob Ali
Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: a controlled, randomized, open-label phase II trial.
The oncologist 2007;12(6):727-37.
2007: Ramalingam Suresh S; Parise Robert A; Ramanathan Ramesh K; Lagattuta Theodore F; Musguire Lori A; Stoller Ronald G; Potter Douglas M; Argiris Athanassios E; Zwiebel James A; Egorin Merrill J; Belani Chandra P
Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(12):3605-10.
2007: Eiseman Julie L; Guo Jianxia; Ramanathan Ramesh K; Belani Chandra P; Solit David B; Scher Howard I; Ivy S Percy; Zuhowski Eleanor G; Egorin Merrill J
Evaluation of plasma insulin-like growth factor binding protein 2 and Her-2 extracellular domain as biomarkers for 17-allylamino-17-demethoxygeldanamycin treatment of adult patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2121-7.
2007: Ramanathan Ramesh K; Kirkpatrick D Lynn; Belani Chandra P; Friedland David; Green Sylvan B; Chow H-H Sherry; Cordova Catherine A; Stratton Steven P; Sharlow Elizabeth R; Baker Amanda; Dragovich Tomislav
A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2109-14.
2007: Ramalingam Suresh; Belani Chandra P
Role of bevacizumab for the treatment of non-small-cell lung cancer.
Future oncology (London, England) 2007;3(2):131-9.
2007: Crawford Jeffrey; Robert Francisco; Perry Michael C; Belani Chandra; Williams Denise;
A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(3):210-20.
2007: Ramanathan Ramesh K; Egorin Merrill J; Eiseman Julie L; Ramalingam Suresh; Friedland David; Agarwala Sanjiv S; Ivy S Percy; Potter Douglas M; Chatta Gurkamal; Zuhowski Eleanor G; Stoller Ronald G; Naret Cynthia; Guo Jianxia; Belani Chandra P
Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1769-74.
2007: Ramalingam Suresh; Belani Chandra P
Recent advances in targeted therapy for non-small cell lung cancer.
Expert opinion on therapeutic targets 2007;11(2):245-57.
2007: Obasaju Coleman K; Ye Zhishen; Wozniak Antoinette J; Belani Chandra P; Keohan Mary-Louise; Ross Helen J; Polikoff Jonathan A; Mintzer David M; Monberg Matthew J; Jänne Pasi A;
Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
Lung cancer (Amsterdam, Netherlands) 2007;55(2):187-94.
2007: Belani Chandra P; Marts Sherry; Schiller Joan; Socinski Mark A
Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research.
Lung cancer (Amsterdam, Netherlands) 2007;55(1):15-23.
2007: Belani C P; Dakhil S; Waterhouse D M; Desch C E; Rooney D K; Clark R H; Monberg M J; Ye Z; Obasaju C K
Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(1):110-5.
2006: Gerszten Peter C; Burton Steven A; Belani Chandra P; Ramalingam Suresh; Friedland David M; Ozhasoglu Cihat; Quinn Annette E; McCue Kevin J; Welch William C
Radiosurgery for the treatment of spinal lung metastases.
Cancer 2006;107(11):2653-61.
2006: Govindan Ramaswamy; Natale Ronald; Wade James; Herbst Roy; Krebs Annetta; Reiling Richard; Hensing Thomas; Wozniak Antoinette; Belani Chandra P; Kelly Karen; Ochs Judith
Efficacy and safety of gefitinib in chemonaive patients with advanced non-small cell lung cancer treated in an Expanded Access Program.
Lung cancer (Amsterdam, Netherlands) 2006;53(3):331-7.
2006: Belani Chandra P; Pereira Jose R; von Pawel Joachim; Pluzanska Anna; Gorbounova Vera; Kaukel Eckhard; Mattson Karin V; Ramlau Rodryg; Szczesna Aleksandra; Fidias Panos; Millward Michael; Fossella Frank;
Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.
Lung cancer (Amsterdam, Netherlands) 2006;53(2):231-9.
2006: Jänne Pasi A; Wozniak Antoinette J; Belani Chandra P; Keohan Mary-Louise; Ross Helen J; Polikoff Jonathan A; Mintzer David M; Ye Zhishen; Monberg Matthew J; Obasaju Coleman K;
Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(6):506-12.
2006: Wakelee Heather A; Wang Wei; Schiller Joan H; Langer Corey J; Sandler Alan B; Belani Chandra P; Johnson David H;
Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(5):441-6.
2006: Dacic Sanja; Flanagan Melina; Cieply Kathleen; Ramalingam Suresh; Luketich James; Belani Chandra; Yousem Samuel A
Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma.
American journal of clinical pathology 2006;125(6):860-5.
2006: Albain Kathy S; Belani Chandra P; Bonomi Philip; O'Byrne Kenneth J; Schiller Joan H; Socinski Mark
PIONEER: a phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2.
Clinical lung cancer 2006;7(6):417-9.
2006: Ramanathan Ramesh K; Fakih Marwan; Mani Sridhar; Deutsch Melvin; Perez Raymond P; Ritter Mark A; Eiseman Julie L; Ivy S Percy; Trump Donald L; Belani Chandra P; Parise Robert A; Potter Douglas M; Egorin Merrill J
Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers.
Cancer chemotherapy and pharmacology 2006;57(4):465-74.
2006: Ramalingam Suresh; Barstis John; Perry Michael C; La Rocca Renato V; Nattam Sreenivasa R; Rinaldi David; Clark Ray; Mills Glenn M; Belani Chandra P
Treatment of elderly non-small cell lung cancer patients with three different schedules of weekly paclitaxel in combination with carboplatin: subanalysis of a randomized trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(3):240-4.
2005: Belani Chandra P
Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxel.
Lung cancer (Amsterdam, Netherlands) 2005;50 Suppl 2():S3-8.
2005: Ramalingam Suresh; Belani Chandra P
Molecularly-targeted therapies for non-small cell lung cancer.
Expert opinion on pharmacotherapy 2005;6(15):2667-79.
2005: Belani Chandra P; Fossella Frank
Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326).
Cancer 2005;104(12):2766-74.
2005: Wolski Michal J; Bhatnagar Ajay; Flickinger John C; Belani Chandra P; Ramalingam Suresh; Greenberger Joel S
Multivariate analysis of survival, local control, and time to distant metastases in patients with unresectable non-small-cell lung carcinoma treated with 3-dimensional conformal radiation therapy with or without concurrent chemotherapy.
Clinical lung cancer 2005;7(2):100-6.
2005: Belani Chandra P; Choy Hak; Bonomi Phil; Scott Charles; Travis Patrick; Haluschak John; Curran Walter J
Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):5883-91.
2005: Jänne Pasi A; Wozniak Anoinette J; Belani Chandra P; Keohan Mary-Louise; Ross Helen J; Polikoff Jonathan A; Mintzer David M; Taylor Loretta; Ashland Joseph; Ye Zhishen; Monberg Matthew J; Obasaju Coleman K
Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.
Clinical lung cancer 2005;7(1):40-6.
2005: Belani Chandra P; Ramalingam Suresh
Molecular predictors of sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor: confusion or clarity?
Clinical lung cancer 2005;7(1):8.
2005: Belani C P; Lee J S; Socinski M A; Robert F; Waterhouse D; Rowland K; Ansari R; Lilenbaum R; Natale R B
Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1069-75.
2005: Belani Chandra P; Wang Wei; Johnson David H; Wagner Henry; Schiller Joan; Veeder Michael; Mehta Minesh;
Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3760-7.
2005: Belani Chandra P
The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer.
Clinical lung cancer 2005;6(6):331-2.
2005: Ramanathan Ramesh K; Trump Donald L; Eiseman Julie L; Belani Chandra P; Agarwala Sanjiv S; Zuhowski Eleanor G; Lan Jing; Potter Douglas M; Ivy S Percy; Ramalingam Sakkaraiappan; Brufsky Adam M; Wong Michael K K; Tutchko Susan; Egorin Merrill J
Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3385-91.
2005: Mohamed M K; Ramalingam S; Lin Y; Gooding W; Belani C P
Skin rash and good performance status predict improved survival with gefitinib in patients with advanced non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(5):780-5.
2005: Cella David; Herbst Roy S; Lynch Thomas J; Prager Diane; Belani Chandra P; Schiller Joan H; Heyes Anne; Ochs Judith S; Wolf Michael K; Kay Andrea C; Kris Mark G; Natale Ronald B
Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):2946-54.
2005: Belani Chandra P
Adjuvant and neoadjuvant therapy in non-small cell lung cancer.
Seminars in oncology 2005;32(2 Suppl 2):S9-15.
2005: Ramanathan Ramesh K; Ramalingam Sakkaraiappan; Egorin Merrill J; Belani Chandra P; Potter Douglas M; Fakih Marwan; Jung Laura L; Strychor Sandra; Jacobs Samuel A; Friedland David M; Shin Dong M; Chatta Gurkamal S; Tutchko Susan; Zamboni William C
Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies.
Cancer chemotherapy and pharmacology 2005;55(4):354-60.
2005: Belani Chandra P; Ramalingam Sakkaraiappan
Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancer.
Clinical lung cancer 2005;6(5):267-8.
2005: Fernando Hiran C; De Hoyos Alberto; Landreneau Rodney J; Gilbert Sebastian; Gooding William E; Buenaventura Percival O; Christie Neil A; Belani Chandra; Luketich James D
Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.
The Journal of thoracic and cardiovascular surgery 2005;129(3):639-44.
2005: Wakelee Heather; Ramalingam Sakkaraiappan; Belani Chandra P
Docetaxel in advanced non-small cell lung cancer.
Expert review of anticancer therapy 2005;5(1):13-24.
2005: Price Nancy; Belani Chandra
Clinical development of gefitinib in non-small-cell lung cancer and the Iressa Survival Evaluation in Lung Cancer trial.
Clinical lung cancer 2005;6(4):214-6.
2005: Belani Chandra P; Ramalingam Sakkaraiappan
Implications of the Iressa Survival Evaluation in Lung Cancer trial and the future of gefitinib.
Clinical lung cancer 2005;6(4):203-4.
2005: Wakelee Heather; Belani Chandra P
Optimizing first-line treatment options for patients with advanced NSCLC.
The oncologist 2005;10 Suppl 3():1-10.
2004: Belani Chandra P
Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma.
Seminars in oncology 2004;31(6 Suppl 14):25-33.
2004: Belani Chandra P; Eckardt John
Development of docetaxel in advanced non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;46 Suppl 2():S3-11.
2004: Belani Chandra P
Integration of docetaxel in the management of non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;46 Suppl 2():S1-2.
2004: Belani Chandra P
Emerging advances in the management of lung cancer.
Clinical lung cancer 2004;6 Suppl 2():S60.
2004: Belani Chandra P
Emerging role of erlotinib (OSI-774) in non-small-cell lung cancer.
Clinical lung cancer 2004;6 Suppl 1():S6.
2004: Jung Laura L; Ramanathan Ramesh K; Egorin Merrill J; Jin Ruzhi; Belani Chandra P; Potter Douglas M; Strychor Sandra; Trump Donald L; Walko Christine; Fakih Marwan; Zamboni William C
Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors.
Cancer chemotherapy and pharmacology 2004;54(6):487-96.
2004: Fernando Hiran C; Hoyos Alberto De; Litle Virginia; Belani Chandra P; Luketich James D
Radiofrequency ablation: identification of the ideal patient.
Clinical lung cancer 2004;6(3):149-53.
2004: Belani Chandra P; Adjei Alex
Combining targeted agents in lung cancer.
Clinical lung cancer 2004;6(3):138.
2004: Belani Chandra P
Challenges in advanced NSCLC: optimizing platinum-based chemotherapy and treating special populations.
Journal of the National Comprehensive Cancer Network : JNCCN 2004;2 Suppl 2():S10-22.
2004: Zamboni William C; Jung Laura L; Egorin Merrill J; Potter Douglas M; Friedland David M; Belani Chandra P; Agarwala Sanjiv S; Wong Michael M W; Fakih Marwan; Trump Donald L; Jin Ruzhi; Strychor Sandra; Vozniak Michael; Troetschel Monica; Ramanathan Ramesh K
Phase I and pharmacologic study of intermittently administered 9-nitrocamptothecin in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5058-64.
2004: Ramalingam Sakkaraiappan; Belani Chandra P
Paclitaxel for non-small cell lung cancer.
Expert opinion on pharmacotherapy 2004;5(8):1771-80.
2004: Ramalingam Sakkaraiappan; Belani Chandra P
Carboplatin/gemcitabine combination in advanced NSCLC.
Oncology (Williston Park, N.Y.) 2004;18(8 Suppl 5):21-6.
2004: Belani Chandra P; Adak Sudeshna; Aisner Seena; Stella Philip J; Levitan Nathan; Johnson David H;
Docetaxel for malignant mesothelioma: phase II study of the Eastern Cooperative Oncology Group.
Clinical lung cancer 2004;6(1):43-7.
2004: Belani Chandra P
Neoadjuvant versus adjuvant therapy for resectable non-small-cell lung cancer.
Clinical lung cancer 2004;6(1):8.
2004: Belani Chandra P
Epidermal growth factor receptor mutations: a new insight.
Clinical lung cancer 2004;5(6):328.
2004: Ramalingam Sakkaraiappan; Dobbs Tracy W; Einzig Avi I; Wojtowicz-Praga Slawomir; Cascino Marianne; Bonomi Phillip; Belani Chandra P
Carboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study.
Cancer chemotherapy and pharmacology 2004;53(5):439-44.
2004: Belani Chandra P; Ramalingam Sakkaraiappan
Smoking cessation and treatment outcome.
Clinical lung cancer 2004;5(5):264.
2004: Ramalingam Sakkaraiappan; Belani Chandra P
Basic treatment considerations: chemotherapy.
Hematology/oncology clinics of North America 2004;18(1):13-28.
2004: Ramalingam Sakkaraiappan; Belani Chandra P
State-of-the-art chemotherapy for advanced non-small cell lung cancer.
Seminars in oncology 2004;31(1 Suppl 1):68-74.
2004: Ramalingam S; Belani C P; Day R; Zamboni B A; Jacobs S A; Jett J R
Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):247-51.
2004: Ramalingam Sakkaraiappan; Belani Chandra P
Cyclooxygenase-2 inhibitors in lung cancer.
Clinical lung cancer 2004;5(4):245-53.
2004: Belani Chandra P; Ramalingam Sakkaraiappan
Lung cancer: looking ahead in 2004.
Clinical lung cancer 2004;5(4):200.
2004: Weinberg Rebecca; Kaurin Darryl G L; Choy Hak; Curran Walter J; MacRae Robert; Kim Jae Sung; Kim Jaechul; Tucker Susan L; Bonomi Philip D; Belani Chandra; Starkschall George
Dosimetric uncertainties of three-dimensional dose reconstruction from two-dimensional data in a multi-institutional study.
Journal of applied clinical medical physics / American College of Medical Physics 2004;5(4):15-28.
2003: Belani Chandra P
Clinical lung cancer indexed in Index Medicus and Medline.
Clinical lung cancer 2003;5(3):137.
2003: Ramalingam Sakkaraiappan; Belani Chandra P
Results of clinical trials for locally advanced and metastatic nonsmall-cell lung cancer.
Seminars in thoracic and cardiovascular surgery 2003;15(4):438-47.
2003: Kris Mark G; Natale Ronald B; Herbst Roy S; Lynch Thomas J; Prager Diane; Belani Chandra P; Schiller Joan H; Kelly Karen; Spiridonidis Harris; Sandler Alan; Albain Kathy S; Cella David; Wolf Michael K; Averbuch Steven D; Ochs Judith J; Kay Andrea C
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
JAMA : the journal of the American Medical Association 2003;290(16):2149-58.
2003: Belani Chandra P
Elderly patients with advanced non-small-cell lung cancer.
Clinical lung cancer 2003;5(2):76.
2003: Belani Chandra P; Barstis John; Perry Michael C; La Rocca Renato V; Nattam Sreenivasa R; Rinaldi David; Clark Ray; Mills Glenn M
Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2933-9.
2003: Bunn Paul A; Shepherd Frances A; Sandler Alan; Le Chevalier Thierry; Belani Chandra P; Kosmidis Paris A; Scagliotti Giorgio V; Giaccone Giuseppe
Ongoing and future trials of biologic therapies in lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;41 Suppl 1():S175-86.
2003: Fossella Frank; Pereira Jose R; von Pawel Joachim; Pluzanska Anna; Gorbounova Vera; Kaukel Eckhard; Mattson Karin V; Ramlau Rodryg; Szczesna Aleksandra; Fidias Panagiotis; Millward Michael; Belani Chandra P
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3016-24.
2003: Belani Chandra P
Early-stage non-small-cell lung cancer: adjuvant versus neoadjuvant chemotherapy.
Clinical lung cancer 2003;5(1):11-2.
2003: Belani Chandra P
Gefitinib for non-small cell lung cancer: is the efficacy real?
Clinical lung cancer 2003;4(6):330.
2003: Belani Chandra P
Antinsense oligonucleotides in lung cancer: do they really make sense?
Clinical lung cancer 2003;4(5):266.
2003: Belani Chandra P
Newer cytotoxic and targeted agents are advancing the treatment of lung cancer.
Clinical lung cancer 2003;4 Suppl 2():S39.
2003: Belani Chandra P
Adjuvant therapy for surgically resected non-small-cell lung cancer: will it become a reality?
Clinical lung cancer 2003;4(4):203-4.
2002: Belani Chandra P; Langer Corey;
First-line chemotherapy for NSCLC: an overview of relevant trials.
Lung cancer (Amsterdam, Netherlands) 2002;38 Suppl 4():13-9.
2002: Ramalingam Sakkaraiappan; Belani Chandra P
Taxanes for advanced non-small cell lung cancer.
Expert opinion on pharmacotherapy 2002;3(12):1693-709.
2002: Belani Chandra P
Creating a molecular classification for lung cancer.
Clinical lung cancer 2002;4(3):139.
2002: Ramanathan Ramesh K; Potter Douglas M; Belani Chandra P; Jacobs Samuel A; Gravenstein Stefan; Lim Felix; Kim Hyoung; Savona Steven; Evans Terry; Buchbarker Dianne; Simon Mary B; Depee Jane K; Trump Donald L
Randomized trial of influenza vaccine with granulocyte-macrophage colony-stimulating factor or placebo in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4313-8.
2002: Ramalingam Sakkaraiappan; Belani Chandra P
Impact of INTACT: do we change the target or the aim?
Clinical lung cancer 2002;4(2):75.
2002: Ramalingam Sakkaraiappan; Belani Chandra P
Doublet chemotherapy for advanced non-small cell lung cancer.
Clinical lung cancer 2002;4(1):13.
2002: Belani Chandra P;
Docetaxel in combination with platinums (cisplatin or carboplatin) in advanced and metastatic non-small cell lung cancer.
Seminars in oncology 2002;29(3 Suppl 12):4-9.
2002: Belani Chandra P; Sauder Ryan J
Docetaxel/platinum in advanced non-small-cell lung cancer: recent randomized trials.
Clinical lung cancer 2002;3 Suppl 2():S7-11.
2002: Bhatnagar Ajay; Flickinger John C; Bahri Sanjeev; Deutsch Melvin; Belani Chandra; Luketich James D; Greenberger Joel S
Update on results of multifield conformal radiation therapy of non-small-cell lung cancer using multileaf collimated beams.
Clinical lung cancer 2002;3(4):259-64.
2002: Belani Chandra P
Chemotherapy regimens in advanced non-small-cell lung cancer: recent randomized trials.
Clinical lung cancer 2002;3 Suppl 1():S5-9.
2002: Belani Chandra P
Extensive-stage small-cell lung cancer: is the progress real?
Clinical lung cancer 2002;3(3):168.
2002: Ramalingam Sakkaraiappan; Belani Chandra P
Meaningful survival in lung cancer patients.
Seminars in oncology 2002;29(1 Suppl 4):125-31.
2002: Schiller Joan H; Harrington David; Belani Chandra P; Langer Corey; Sandler Alan; Krook James; Zhu Junming; Johnson David H;
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.
The New England journal of medicine 2002;346(2):92-8.
2001: Belani C P
Lung cancer: search for a marker.
Clinical lung cancer 2001;3(2):91.
2001: Sweeney C J; Zhu J; Sandler A B; Schiller J; Belani C P; Langer C; Krook J; Harrington D; Johnson D H
Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma .
Cancer 2001;92(10):2639-47.
2001: Belani C P
Individualized therapy for non-small cell lung cancer.
Clinical lung cancer 2001;3(1):11.
2001: Belani C P
Interim analysis of a phase II study of induction weekly paclitaxel/carboplatin regimens followed by maintenance weekly paclitaxel for advanced and metastatic non-small cell lung cancer.
Seminars in oncology 2001;28(4 Suppl 14):14-6.
2001: Belani C;
Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non--small cell lung cancer: interim analysis.
Seminars in oncology 2001;28(3 Suppl 9):10-4.
2001: Shihabi S; Belani C P
Role of topoisomerase I inhibitors in small-cell lung cancer.
Clinical lung cancer 2001;2(4):275-81.
2001: Belani C P
Targets...targets...targets... Targeted therapies in lung cancer.
Clinical lung cancer 2001;2(4):251.
2001: Luketich J D; Friedman D M; Meltzer C C; Belani C P; Townsend D W; Christie N A; Weigel T L
The role of positron emission tomography in evaluating mediastinal lymph node metastases in non-small-cell lung cancer.
Clinical lung cancer 2001;2(3):229-33.
2001: Belani C; Lynch T
Docetaxel (Taxotere) in combination with platinums in patients with non-small cell lung cancer: trial data and implications for clinical management.
Seminars in oncology 2001;28(1 Suppl 2):10-4.
2001: Calvo A R; Belani C P
Lung cancer: therapeutic options for stage IV and recurrent NSCLC.
Cancer treatment and research 2001;105():189-227.
2000: Belani C P
Chemotherapy regimens in advanced non small-cell lung cancer: recent randomized trials.
Clinical lung cancer 2000;2 Suppl 1():S7-S10.
2000: Belani C P
Locally advanced, unresectable non-small cell lung cancer shift in the treatment paradigm.
Clinical lung cancer 2000;2(2):90.
2000: Luketich J D; Meehan M A; Landreneau R J; Christie N A; Close J M; Ferson P F; Keenan R J; Belani C P
Total videothoracoscopic lobectomy versus open thoracotomy for early-stage non small-cell lung cancer.
Clinical lung cancer 2000;2(1):56-60; discussion 61.
2000: Belani C P
Non-small-cell lung cancer have we reached a "chemotherapy efficacy plateau"?
Clinical lung cancer 2000;2(1):10.
2000: Belani C P; Einzig A; Bonomi P; Dobbs T; Capozzoli M J; Earhart R; Cohen L J; Luketich J D
Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(6):673-8.
2000: Greenberger J S; Epperly M; Luketich J; Gooding W; Belani C P
Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) gene therapy protection of the esophagus from chemoradiotherapy damage during treatment of locally unresectable non-small-cell lung cancer (NSCLC).
Clinical lung cancer 2000;1(4):302-4.
2000: Belani C P
Clinical lung cancer - a promising start.
Clinical lung cancer 2000;1(4):249.
2000: Belani C P
Docetaxel in combination with platinum compounds for non small-cell lung cancer.
Clinical lung cancer 2000;1 Suppl 1():S10-4.
2000: Belani C P
Paclitaxel and docetaxel combinations in non-small cell lung cancer.
Chest 2000;117(4 Suppl 1):144S-151S.
2000: Belani C P
Combined modality therapy for unresectable stage III non-small cell lung cancer: new chemotherapy combinations.
Chest 2000;117(4 Suppl 1):127S-132S.
2000: Ramanathan R K; Rubin J T; Ohori N P; Belani C P
Dramatic response of adult wilms tumor to paclitaxel and cisplatin.
Medical and pediatric oncology 2000;34(4):296-8.
2000: Belani C P
Lung cancer in the new millennium.
Clinical lung cancer 2000;1(3):169.
2000: Gandara D R; Vokes E; Green M; Bonomi P; Devore R; Comis R; Carbone D; Karp D; Belani C
Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(1):131-5.
1999: Belani C P; Bonomi P; Dobbs T W; DeVore R F; Ettinger D S; Jett J; Luketich J D; Cohen L J; Johnson D H
Docetaxel and cisplatin in patients with advanced non small-cell lung cancer (NSCLC): a multicenter phase II trial.
Clinical lung cancer 1999;1(2):144-50.
1999: Fossella F; Rigas J R; Belani C P
New options in the treatment of non-small cell lung cancer.
Anti-cancer drugs 1999;10 Suppl 1():S25-8.
1999: Kindler H L; Belani C P; Herndon J E; Vogelzang N J; Suzuki Y; Green M R
Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B.
Cancer 1999;86(10):1985-91.
1999: Luketich J D; Nguyen N T; Weigel T L; Keenan R J; Ferson P F; Belani C P
Photodynamic therapy for treatment of malignant dysphagia.
Surgical laparoscopy, endoscopy & percutaneous techniques 1999;9(3):171-5.
1999: Belani C P
Docetaxel (Taxotere) in combination with platinum-based regimens in non-small cell lung cancer: results and future developments.
Seminars in oncology 1999;26(3 Suppl 10):15-8.
1999: Selvaggi G; Belani C P
Carboplatin and paclitaxel in non-small cell lung cancer: the role of amifostine.
Seminars in oncology 1999;26(2 Suppl 7):51-60.
1999: Belani C P
Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
Seminars in oncology 1999;26(1 Suppl 2):44-54.
1999: Belani C P; Kearns C M; Zuhowski E G; Erkmen K; Hiponia D; Zacharski D; Engstrom C; Ramanathan R K; Capozzoli M J; Aisner J; Egorin M J
Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):676-84.
1999: Bahri S; Flickinger J C; Kalend A M; Deutsch M; Belani C P; Sciurba F C; Luketich J D; Greenberger J S
Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
Radiation oncology investigations 1999;7(5):297-308.
1998: Treat J; Johnson E; Langer C; Belani C; Haynes B; Greenberg R; Rodriquez R; Drobins P; Miller W; Meehan L; McKeon A; Devin J; von Roemeling R; Viallet J
Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(11):3524-7.
1998: Kassis E S; Belani C P; Ferson P F; Keenan R J; Luketich J D
Hodgkin's disease presenting with a bronchoesophageal fistula.
The Annals of thoracic surgery 1998;66(4):1409-10.
1998: Rishi A K; Yu M; Tsai-Wu J J; Belani C P; Fontana J A; Baker D L; Periasamy M; Hussain A
Gene amplification and transcriptional upregulation of the sarco/endoplasmic reticulum Ca2+ transport ATPase in thapsigargin-resistant hamster smooth muscle cells.
Nucleic acids research 1998;26(19):4529-37.
1998: Belani C P
Single agents in the second-line treatment of non-small cell lung cancer.
Seminars in oncology 1998;25(3 Suppl 8):10-4.
1998: Belani C P
Paclitaxel/carboplatin in the treatment of non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 1998;12(1 Suppl 2):74-9.
1998: Belani C P; Pajeau T S; Bennett C L
Treating malignant pleural effusions cost consciously.
Chest 1998;113(1 Suppl):78S-85S.
1998: Belani C P; Ramanathan R K
Combined-modality treatment of locally advanced non-small cell lung cancer: incorporation of novel chemotherapeutic agents.
Chest 1998;113(1 Suppl):53S-60S.
1998: Greenberger J S; Bahri S; Jett J; Belani C; Kalend A; Epperly M
Considerations in optimizing radiation therapy for non-small cell lung cancer.
Chest 1998;113(1 Suppl):46S-52S.
1997: Belani C P; Luketich J D; Landreaneau R J; Kim R; Ramanathan R K; Day R; Ferson P F; Keenan R J; Posner M; Seeger J; Lembersky B
Efficacy of cisplatin, 5-fluorouracil, and paclitaxel regimen for carcinoma of the esophagus.
Seminars in oncology 1997;24(6 Suppl 19):S19-89-S19-92.
1997: Luketich J D; Schauer P; Urso K; Townsend D W; Belani C P; Cidis Meltzer C; Ferson P F; Keenan R J
Minimally invasive surgical biopsy confirms PET findings in esophageal cancer.
Surgical endoscopy 1997;11(12):1213-5.
1997: Luketich J D; Schauer P R; Meltzer C C; Landreneau R J; Urso G K; Townsend D W; Ferson P F; Keenan R J; Belani C P
Role of positron emission tomography in staging esophageal cancer.
The Annals of thoracic surgery 1997;64(3):765-9.
1997: Belani C P
Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 1997;11(8 Suppl 8):42-5.
1997: Ramanathan R K; Belani C P
Chemotherapy for advanced non-small cell lung cancer: past, present, and future.
Seminars in oncology 1997;24(4):440-54.
1996: Belani C P; Aisner J; Bahri S; Jett J; Day R; Capazolli M J; Hiponia D; Engstrom C
Chemoradiotherapy in non-small cell lung cancer: paclitaxel/carboplatin/radiotherapy in regionally advanced disease.
Seminars in oncology 1996;23(6 Suppl 16):113-6.
1996: Belani C P; Aisner J; Hiponia D; Ramanathan R
Paclitaxel and carboplatin in metastatic non-small cell lung cancer: preliminary results of a phase I study.
Seminars in oncology 1996;23(5 Suppl 12):19-21.
1996: Ramanathan R K; Reddy V V; Holbert J M; Belani C P
Pulmonary infiltrates following administration of paclitaxel.
Chest 1996;110(1):289-92.
1996: Ramanathan R K; Belani C P
Transient pulmonary infiltrates: a hypersensitivity reaction to paclitaxel.
Annals of internal medicine 1996;124(2):278.
1995: Aisner J; Belani C P; Kearns C; Conley B; Hiponia D; Engstrom C; Zuhowski E; Egorin M J
Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer.
Seminars in oncology 1995;22(5 Suppl 12):17-21.
1995: Kearns C M; Belani C P; Erkmen K; Zuhowski M; Hiponia D; Zacharski D; Engstrom C; Ramanathan R; Trenn M R; Aisner J
Pharmacokinetics of paclitaxel and carboplatin in combination.
Seminars in oncology 1995;22(5 Suppl 12):1-4; discussion 5-7.
1995: Doyle L A; Ross D D; Ordonez J V; Yang W; Gao Y; Tong Y; Belani C P; Gutheil J C
An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.
British journal of cancer 1995;72(3):535-42.
1995: Belani C P; Aisner J; Hiponia D; Engstrom C
Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer.
Seminars in oncology 1995;22(4 Suppl 9):7-12.
1995: Hainsworth J D; Levitan N; Wampler G L; Belani C P; Seyedsadr M S; Randolph J; Schacter L P; Greco F A
Phase II randomized study of cisplatin plus etoposide phosphate or etoposide in the treatment of small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1436-42.
1995: Aisner J; Hiponia D; Conley B; Jacobs M; Gray W; Belani C P
Combined modalities in the treatment of head and neck cancers.
Seminars in oncology 1995;22(3 Suppl 6):28-34.
1995: White C S; Haramati L B; Elder K H; Karp J; Belani C P
Carcinoma of the lung in HIV-positive patients: findings on chest radiographs and CT scans.
AJR. American journal of roentgenology 1995;164(3):593-7.
1995: Vokes E E; Rosenberg R K; Jahanzeb M; Craig J B; Gralla R J; Belani C P; Jones S E; Bigley J W; Hohneker J A
Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):637-44.
1994: Vokes E E; Rosenberg R; Jahanzeb M; Craig J; Gralla R; Belani C; Jones S; Bigley J; Hohneker J
Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: a preliminary report.
Seminars in oncology 1994;21(5 Suppl 10):35-8; discussion 38-41.
1994: Belani C P; Aisner J
Combined chemotherapy and radiation in locally advanced non-small cell lung cancer.
Seminars in oncology 1994;21(3 Suppl 6):79-90.
1994: Flores J F; Rude R K; Chapman R A; Belani C P; Chang A Y; Pritchard J D; Hoff J V
Evaluation of a 24-hour infusion of etidronate disodium for the treatment of hypercalcemia of malignancy.
Cancer 1994;73(10):2527-34.
1994: Hollen P J; Gralla R J; Kris M G; Cox C; Belani C P; Grunberg S M; Crawford J; Neidhart J A
Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale.
Cancer 1994;73(8):2087-98.
1994: Bleehen N M; Ball D; Belani C P; Bishop J; Douillard J Y; Cox J D; Johnson D H; Le Chevalier T; Saunders M I; Shaw E
Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands) 1994;10 Suppl 1():S19-23.
1994: Cox J; Ball D; Belani C; Choi N; Gralla R; Halle J; Komaki R; Le Chevalier T; Ohnoshi T; Quoix E
Dose intensity in lung cancer treatment.
Lung cancer (Amsterdam, Netherlands) 1994;10 Suppl 1():S11-3.
1994: Gutheil J C; Hart S R; Belani C P; Melera P W; Hussain A
Alterations in Ca2+ transport ATPase and P-glycoprotein expression can mediate resistance to thapsigargin.
The Journal of biological chemistry 1994;269(11):7976-81.
1994: Belani C P; Belcher A E; Sridhara R; Schimpff S C
Instruction in the techniques and concept of supportive care in oncology.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1994;2(1):50-5.
1994: Belani C P; Doyle L A; Aisner J
Etoposide: current status and future perspectives in the management of malignant neoplasms.
Cancer chemotherapy and pharmacology 1994;34 Suppl():S118-26.
1993: Belani C P
Multimodality management of regionally advanced non-small-cell lung cancer.
Seminars in oncology 1993;20(4):302-14.
1993: Aisner J; Belani C P
Lung cancer: recent changes and expectations of improvements.
Seminars in oncology 1993;20(4):383-93.
1993: Abrams J S; Eiseman J L; Melink T J; Sridhara R; Hiponia D J; Bell M M; Belani C P; Adler W H; Aisner J
Immunomodulation of interleukin-2 by cyclophosphamide: a phase IB trial.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;14(1):56-64.
1993: White C S; Templeton P A; Belani C P
Imaging in lung cancer.
Seminars in oncology 1993;20(2):142-52.
1992: Belani C P; Aisner J
Combined-modality therapies for non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 3():3-10.
1992: Kruter F; Eisenberger M; Sinibaldi V; Engstrom C; Jacobs M; Abrams J; Belani C; Gray W; Krasnow S
Phase II trial of 5 day continuous intravenous infusion of 6-thioguanine in patients with recurrent and metastatic squamous cell carcinoma of the head and neck.
Investigational new drugs 1992;10(2):89-91.
1990: Belani C P; Aisner J
Therapy for small cell and non-small cell lung cancer.
Current opinion in oncology 1990;2(2):334-44.
1989: Belani C P; Egorin M J; Abrams J S; Hiponia D; Eisenberger M; Aisner J; Van Echo D A
A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(12):1896-902.
1989: Belani C P; Van Echo D A; Aisner J
Platinum compounds.
Current opinion in oncology 1989;1(2):186-91.
1989: Whitley N O; Belani C P; Aisner J; Forrest A; Whitley J
Tumor volume and treatment outcome in small cell lung carcinoma.
Investigative radiology 1989;24(8):581-4.
1989: Egorin M J; Forrest A; Belani C P; Ratain M J; Abrams J S; Van Echo D A
A limited sampling strategy for cyclophosphamide pharmacokinetics.
Cancer research 1989;49(11):3129-33.
1989: Belani C P; Pearl P; Whitley N O; Aisner J
Tamoxifen withdrawal response. Report of a case.
Archives of internal medicine 1989;149(2):449-50.
1988: Belani C P; Eisenberger M A; Gray W C
Preliminary experience with chemotherapy in advanced salivary gland neoplasms.
Medical and pediatric oncology 1988;16(3):197-202.
1987: Belani C P; Eisenberger M; Van Echo D; Hiponia D; Aisner J
Phase II study of caracemide in advanced or recurrent non-small cell lung cancer.
Cancer treatment reports 1987;71(11):1099-100.
1986: Berg R A; Belani A; Belani C P
Vasculitis in a suspected AIDS patient.
Southern medical journal 1986;79(7):914-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Chandra Belani

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Chandra Belani (preview)

All Publications